Clinical trial
A Natural History Study of Patients With Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2)
NCT03478839 is registered in ClinicalTrials.gov with National Human Genome Research Institute (NHGRI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Natural History Study of Patients With Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2)
- Lead sponsor
- National Human Genome Research Institute (NHGRI)
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 17, 2018
- Completion date
- December 31, 2020
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autosomal recessive hypophosphatemic rickets type2, generalized arterial calcification of infancy